DUALITAS THERAPEUTICS
HQ - South San Francisco
Summary
Dualitas Therapeutics is a biotechnology company developing bispecific antibody therapies for immunology and inflammation.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 48 M
Avg. Deal Size£ 48 M
All rights reserved. Copyright © 2025 Datasite
